Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • captainentropy
    Member
    • Mar 2009
    • 89

    Optimum input DNA sequencing depth

    I've been told recently that I need to be generating at least 1X coverage of the genome for the input DNA sequencing.

    It makes sense to do so but I'm wondering what other labs do. On a GAII that's about 5 lanes of sequencing assuming 20M reads per lane and 36bp reads.
  • krobison
    Senior Member
    • Nov 2007
    • 734

    #2
    For what are you using the data? The amount you need to generate is completely dependent on the application.

    Comment

    • captainentropy
      Member
      • Mar 2009
      • 89

      #3
      ChIP-seq. The input is for the normalization step.

      Comment

      • GKM
        Member
        • May 2009
        • 45

        #4
        I haven't seen anyone sequence that many reads from their input, 30-40M should be enough. Also, remember that your 1X will not at all be 1X because the input is far from a homogenous representation of the genome.

        Comment

        • captainentropy
          Member
          • Mar 2009
          • 89

          #5
          Right, but that was why it was suggested I need to make sure it's a real 1X, other regions would certainly be many more X for sure. That's the only real way to control for all the endogenous "peaks" of the genome. I think it's unrealistic to do 1X or more for each input but I want it right, not simply what's easiest. 40M reads is about 0.5X. I guess that'll be good enough for now.

          Comment

          • simonandrews
            Simon Andrews
            • May 2009
            • 870

            #6
            Our experience is that 30 million reads of an input sample (40bp) is enough to use as a filter, but not enough to normalise against (assuming a normal sized eukaryotic genome).

            The problem is that over any enriched region you'll have a huge discrepancy between the coverage of your enriched and your input measurement, and as such the input measurement will limit the accuracy of your corrected measure, and small changes to the input can have a big effect on the corrected value.

            What you can do with this much data is to ignore ChIP peaks where you see a corresponding peak in the input sample. These are the things you really need to get rid of and you don't need a huge amount of data to find them. There's even a group (whose name escapes me for the moment, but I can look it up if you're interested) who have created a catalogue of genome regions where they see unusual enrichment in supposedly unbiased input samples - you can just filter against this.

            I should also say that we now don't run input controls for every sample, since the biases you see are generally consistent across samples (as long as you're using the same protocol, species and aligner), so you can merge together the inputs you have and just use those against any new samples.

            Comment

            Latest Articles

            Collapse

            • SEQadmin2
              Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
              by SEQadmin2


              Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

              The systematic characterization of the human proteome has
              ...
              07-20-2026, 11:48 AM
            • SEQadmin2
              Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
              by SEQadmin2



              Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
              ...
              07-09-2026, 11:10 AM
            • SEQadmin2
              Cancer Drug Resistance: The Lingering Barrier to Rising Survival
              by SEQadmin2



              Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

              There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
              07-08-2026, 05:17 AM

            ad_right_rmr

            Collapse

            News

            Collapse

            Topics Statistics Last Post
            Started by SEQadmin2, 07-24-2026, 12:17 PM
            0 responses
            26 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-23-2026, 11:41 AM
            0 responses
            21 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-20-2026, 11:10 AM
            0 responses
            210 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-13-2026, 10:26 AM
            0 responses
            78 views
            0 reactions
            Last Post SEQadmin2  
            Working...